Presented at Asian Regional Drug Development Summit on September 9, 2015, this presentation evaluates the trends and challenges in drug development across complex trials and reviews the importance of biomarker assay use and companion diagnostics (CDx) in drug development. This presentation will also highlight key biomarker and CDx case studies that demonstrate risk mitigation in drug development across various therapeutic areas and provide an overview of China CDx related regulatory. 

Download the presentation to learn more.

Speaker:
Yaozhou Shi, Ph.D., General Manager, Quest Diagnostics Clinical Trials China